{"id":8349,"date":"2025-06-09T17:14:06","date_gmt":"2025-06-09T09:14:06","guid":{"rendered":"https:\/\/regask.com\/?p=8349"},"modified":"2025-06-24T14:57:57","modified_gmt":"2025-06-24T06:57:57","slug":"efficacite-reglementaire-de-loutil-dia-elsa-de-la-fda","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/fda-elsa-ai-tool-regulatory-efficiency\/","title":{"rendered":"La FDA lance \u00ab Elsa \u00bb : un syst\u00e8me g\u00e9n\u00e9ratif \u00e0 l\u2019\u00e9chelle de l\u2019agence\u2026"},"content":{"rendered":"<p data-start=\"278\" data-end=\"655\">Le 2 juin 2025, le <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-launches-agency-wide-ai-tool-optimize-performance-american-people\">Administration am\u00e9ricaine des aliments et des m\u00e9dicaments (FDA)<\/a> Lancement officiel d&#039;Elsa, un outil d&#039;intelligence artificielle (IA) g\u00e9n\u00e9rative d\u00e9velopp\u00e9 pour am\u00e9liorer l&#039;efficacit\u00e9 op\u00e9rationnelle de l&#039;agence. Con\u00e7u dans un environnement GovCloud hautement s\u00e9curis\u00e9, Elsa accompagne un large \u00e9ventail de collaborateurs de la FDA, des examinateurs scientifiques aux enqu\u00eateurs de terrain, dans la gestion de t\u00e2ches complexes et gourmandes en donn\u00e9es.<\/p>\n<h3>Un bond en avant dans les op\u00e9rations r\u00e9glementaires<\/h3>\n<p>Elsa marque une avanc\u00e9e majeure dans la strat\u00e9gie de modernisation num\u00e9rique de la FDA. Con\u00e7ue sp\u00e9cialement pour un usage interne s\u00e9curis\u00e9, Elsa n&#039;utilise pas de donn\u00e9es industrielles confidentielles pour la formation, garantissant ainsi le respect des normes r\u00e9glementaires de confidentialit\u00e9. Ses fonctions actuelles incluent\u00a0:<\/p>\n<ul>\n<li>Synth\u00e8se des documents r\u00e9glementaires<\/li>\n<li>R\u00e9vision des protocoles cliniques<\/li>\n<li>Analyse des \u00e9v\u00e9nements ind\u00e9sirables et des profils de s\u00e9curit\u00e9<\/li>\n<li>Comparaison des \u00e9tiquettes de produits pour la conformit\u00e9<\/li>\n<li>G\u00e9n\u00e9ration de code pour les syst\u00e8mes de bases de donn\u00e9es non cliniques<\/li>\n<\/ul>\n<h3><\/h3>\n<h3>Construit en toute s\u00e9curit\u00e9, con\u00e7u pour \u00e9voluer<\/h3>\n<p>Elsa a \u00e9t\u00e9 d\u00e9velopp\u00e9 dans un environnement conforme au programme FedRAMP et est enti\u00e8rement int\u00e9gr\u00e9 aux syst\u00e8mes internes de la FDA. Lors d&#039;un essai pilote, des \u00e9valuateurs scientifiques ont valid\u00e9 ses capacit\u00e9s. Fort de ce succ\u00e8s, l&#039;outil est d\u00e9sormais d\u00e9ploy\u00e9 \u00e0 l&#039;\u00e9chelle de l&#039;agence.<\/p>\n<h3>Quelle est la prochaine \u00e9tape pour Elsa ?<\/h3>\n<p>Alors qu&#039;Elsa se concentre actuellement sur le r\u00e9sum\u00e9, la r\u00e9daction et le codage, la FDA pr\u00e9voit d&#039;\u00e9tendre son utilisation pour inclure des capacit\u00e9s de traitement de donn\u00e9es plus larges et des applications d&#039;IA g\u00e9n\u00e9ratives suppl\u00e9mentaires \u00e0 l&#039;avenir.<\/p>\n<h3><\/h3>\n<h3>Implications pour les industries r\u00e9glement\u00e9es<\/h3>\n<p>Le d\u00e9ploiement d&#039;Elsa est particuli\u00e8rement pertinent pour les secteurs impliquant des \u00e9valuations cliniques et des revues de s\u00e9curit\u00e9, tels que :<\/p>\n<ul>\n<li>M\u00e9dicaments<\/li>\n<li>Produits biologiques<\/li>\n<li>Dispositifs m\u00e9dicaux<\/li>\n<li>pr\u00e9parations pour nourrissons<\/li>\n<li>Autres produits r\u00e9glement\u00e9s par la FDA<\/li>\n<\/ul>\n<h3>Une voie responsable vers l&#039;adoption de l&#039;IA<\/h3>\n<p>Le lancement d&#039;Elsa souligne l&#039;engagement de la FDA \u00e0 utiliser l&#039;IA de mani\u00e8re responsable, am\u00e9liorant ainsi l&#039;efficacit\u00e9 tout en maintenant une s\u00e9curit\u00e9 stricte des donn\u00e9es et une conformit\u00e9 r\u00e9glementaire.<\/p>\n<hr data-start=\"2195\" data-end=\"2198\" \/>\n<p data-start=\"2200\" data-end=\"2282\"><em data-start=\"2200\" data-end=\"2280\">Pour plus d&#039;informations sur l&#039;innovation pilot\u00e9e par l&#039;IA dans le domaine du renseignement r\u00e9glementaire, suivez <a href=\"https:\/\/www.linkedin.com\/company\/regask\/?viewAsMember=true\">RegASK<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Le 2 juin 2025, la Food and Drug Administration (FDA) am\u00e9ricaine a officiellement lanc\u00e9 Elsa, un outil d&#039;intelligence artificielle (IA) g\u00e9n\u00e9rative con\u00e7u pour am\u00e9liorer l&#039;efficacit\u00e9 op\u00e9rationnelle de l&#039;agence. D\u00e9velopp\u00e9 dans un environnement GovCloud hautement s\u00e9curis\u00e9, Elsa accompagne un large \u00e9ventail d&#039;employ\u00e9s de la FDA, des examinateurs scientifiques aux enqu\u00eateurs de terrain, dans la gestion de t\u00e2ches complexes et gourmandes en donn\u00e9es. Un outil moderne\u2026<\/p>","protected":false},"author":43,"featured_media":8389,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[527,34,39,35],"tags":[633,504,353],"class_list":["post-8349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-united-states-regulations","category-food-beverage-insights","category-medical-devices-insights","category-pharma-biotech-latest-insights","tag-infant-formulae-regulations","tag-labelling-regulations","tag-safety-assessment"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Launches &quot;Elsa&quot;: Agency-Wide Generative AI Tool to Boost Efficiency | RegASK<\/title>\n<meta name=\"description\" content=\"RegASK The FDA introduces Elsa, a secure generative AI tool built to improve clinical reviews, compliance checks, and data analysis across the agency.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/efficacite-reglementaire-de-loutil-dia-elsa-de-la-fda\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Launches &quot;Elsa&quot;: Agency-Wide Generative AI Tool to Boost Efficiency\" \/>\n<meta property=\"og:description\" content=\"RegASK The FDA introduces Elsa, a secure generative AI tool built to improve clinical reviews, compliance checks, and data analysis across the agency.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/efficacite-reglementaire-de-loutil-dia-elsa-de-la-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T09:14:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T06:57:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"FDA Launches &#8220;Elsa&#8221;: Agency-Wide Generative&hellip;\",\"datePublished\":\"2025-06-09T09:14:06+00:00\",\"dateModified\":\"2025-06-24T06:57:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/\"},\"wordCount\":271,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/fda-elsa-ai-tool-regulatory-efficiency-1.png\",\"keywords\":[\"Infant Formulae Regulations\",\"Labelling Regulations\",\"Safety Assessment\"],\"articleSection\":[\"United States\",\"Food and Nutrition\",\"Medical Devices\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/\",\"name\":\"FDA Launches \\\"Elsa\\\": Agency-Wide Generative AI Tool to Boost Efficiency | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/fda-elsa-ai-tool-regulatory-efficiency-1.png\",\"datePublished\":\"2025-06-09T09:14:06+00:00\",\"dateModified\":\"2025-06-24T06:57:57+00:00\",\"description\":\"RegASK The FDA introduces Elsa, a secure generative AI tool built to improve clinical reviews, compliance checks, and data analysis across the agency.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/zh\\\/fda-elsa-ai-tool-regulatory-efficiency\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/fda-elsa-ai-tool-regulatory-efficiency-1.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/fda-elsa-ai-tool-regulatory-efficiency-1.png\",\"width\":800,\"height\":600,\"caption\":\"Fda Elsa Ai Tool Regulatory Efficiency\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA lance \u00ab\u00a0Elsa\u00a0\u00bb\u00a0: un outil d&#039;IA g\u00e9n\u00e9rative \u00e0 l&#039;\u00e9chelle de l&#039;agence pour optimiser son efficacit\u00e9 | RegASK","description":"RegASK La FDA pr\u00e9sente Elsa, un outil d&#039;IA g\u00e9n\u00e9rative s\u00e9curis\u00e9 con\u00e7u pour am\u00e9liorer les examens cliniques, les contr\u00f4les de conformit\u00e9 et l&#039;analyse des donn\u00e9es dans l&#039;ensemble de l&#039;agence.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/efficacite-reglementaire-de-loutil-dia-elsa-de-la-fda\/","og_locale":"fr_FR","og_type":"article","og_title":"FDA Launches \"Elsa\": Agency-Wide Generative AI Tool to Boost Efficiency","og_description":"RegASK The FDA introduces Elsa, a secure generative AI tool built to improve clinical reviews, compliance checks, and data analysis across the agency.","og_url":"https:\/\/regask.com\/fr\/efficacite-reglementaire-de-loutil-dia-elsa-de-la-fda\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-06-09T09:14:06+00:00","article_modified_time":"2025-06-24T06:57:57+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/#article","isPartOf":{"@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"FDA Launches &#8220;Elsa&#8221;: Agency-Wide Generative&hellip;","datePublished":"2025-06-09T09:14:06+00:00","dateModified":"2025-06-24T06:57:57+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/"},"wordCount":271,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png","keywords":["Infant Formulae Regulations","Labelling Regulations","Safety Assessment"],"articleSection":["United States","Food and Nutrition","Medical Devices","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/","url":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/","name":"La FDA lance \u00ab\u00a0Elsa\u00a0\u00bb\u00a0: un outil d&#039;IA g\u00e9n\u00e9rative \u00e0 l&#039;\u00e9chelle de l&#039;agence pour optimiser son efficacit\u00e9 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png","datePublished":"2025-06-09T09:14:06+00:00","dateModified":"2025-06-24T06:57:57+00:00","description":"RegASK La FDA pr\u00e9sente Elsa, un outil d&#039;IA g\u00e9n\u00e9rative s\u00e9curis\u00e9 con\u00e7u pour am\u00e9liorer les examens cliniques, les contr\u00f4les de conformit\u00e9 et l&#039;analyse des donn\u00e9es dans l&#039;ensemble de l&#039;agence.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/zh\/fda-elsa-ai-tool-regulatory-efficiency\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/fda-elsa-ai-tool-regulatory-efficiency-1.png","width":800,"height":600,"caption":"Fda Elsa Ai Tool Regulatory Efficiency"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=8349"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/8389"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=8349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=8349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=8349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}